WEC
46
-4
M
36
2
UHS
58
-2
VTR
55
-6
APD
37
-3
HBI
45
-7
GPC
43
5
UNH
36
-2
AMGN
52
-5
ED
30
-3
FLR
43
3
UA
50
-4
FDX
51
-2
CI
50
-3
MAT
39
-4
A
37
-3
CVS
49
-3
GRMN
59
-3
CB
55
-3
PEG
44
-2
WEC
46
-4
M
36
2
UHS
58
-2
VTR
55
-6
APD
37
-3
HBI
45
-7
GPC
43
5
UNH
36
-2
AMGN
52
-5
ED
30
-3
FLR
43
3
UA
50
-4
FDX
51
-2
CI
50
-3
MAT
39
-4
A
37
-3
CVS
49
-3
GRMN
59
-3
CB
55
-3
PEG
44
-2
Financhill
Back

SPDR® Portfolio Developed Wld ex-US ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
54

SPDW
SPDR® Portfolio Developed Wld ex-US ETF

Last Price:
35.21
Seasonality Move:
0.06%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Buy
54
SPDR® Portfolio Developed Wld ex-US ETF (SPDW) is a Buy

Is SPDR® Portfolio Developed Wld ex-US ETF a Buy, Sell or Hold?

  • The current SPDR® Portfolio Developed Wld ex-US ETF [SPDW] share price is $35.21. The Score for SPDW is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPDW Stock Price Chart

What is SPDR® Portfolio Developed Wld ex-US ETF's stock price today?

  • The SPDR® Portfolio Developed Wld ex-US ETF share price today is $35.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPDW is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 39.84 Sell
Chaikin Money Flow: 1977994 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.59 - 36.43) Sell
Bollinger Bands (100): (34.46 - 36.08) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.51 Sell
20-day SMA: 35.94 Sell
50-day SMA: 35.63 Sell
200-day SMA: 33.69 Buy
8-day EMA: 35.52 Sell
20-day EMA: 35.77 Sell
50-day EMA: 35.68 Sell
200-day EMA: 34.25 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

SPDR® Portfolio Developed Wld ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

SPDR® Portfolio Developed Wld ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):